Nationwide Fund Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Nationwide Fund Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-108,643	Closed	-$2.01M	–	2651
2017 Q3	$2.01M	Sell	108,643 -17,451	-14%	-$292K	0.01%	1444
2017 Q2	$2.13M	Buy	126,094 +13,382	+12%	+$204K	0.01%	1401
2017 Q1	$1.5M	Buy	112,712 +72,361	+179%	+$1.13M	0.01%	1535
2016 Q4	$607K	Sell	40,351 -1,987	-5%	-$26.2K	﹤0.01%	2073
2016 Q3	$495K	Hold	42,338	–	–	﹤0.01%	2187
2016 Q2	$457K	Buy	42,338 +3,030	+8%	+$31.3K	﹤0.01%	2200
2016 Q1	$363K	Sell	39,308 -10,633	-21%	-$114K	﹤0.01%	2257
2015 Q4	$741K	Buy	49,941 +885	+2%	+$14.8K	﹤0.01%	1884
2015 Q3	$805K	Hold	49,056	–	–	﹤0.01%	1842
2015 Q2	$1.12M	Sell	49,056 -1,598	-3%	-$31.8K	﹤0.01%	1788
2015 Q1	$770K	Buy	50,654 +3,733	+8%	+$48.5K	﹤0.01%	2022
2014 Q4	$565K	Buy	46,921 +4,910	+12%	+$56.1K	﹤0.01%	2111
2014 Q3	$476K	Sell	42,011 -181	-0.4%	-$2.06K	﹤0.01%	2251
2014 Q2	$510K	Buy	42,192 +559	+1%	+$6.6K	﹤0.01%	2251
2014 Q1	$485K	Buy	41,633 +152	+0.4%	+$2.57K	﹤0.01%	2076
2013 Q4	$733K	Sell	41,481 -1,117	-3%	-$18.8K	﹤0.01%	2046
2013 Q3	$613K	Buy	42,598 +6,966	+20%	+$107K	﹤0.01%	2117
2013 Q2	$537K	Buy	+35,632	New	+$470K	﹤0.01%	1986

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nationwide Fund Advisors's MNTA Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2017, closing a stake of 108,643 shares — an estimated $2.01M sold.

Nationwide Fund Advisors first reported a position in MNTA in Q2 2013 and held it in 18 quarters. The position peaked at $2.13M in Q2 2017. 166 funds tracked by Wall St. Rank hold MNTA as of Q4 2017.

Nationwide Fund Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Nationwide Fund Advisors sold 108,643 Momenta Pharmaceuticals, Inc. shares in Q4 2017, an estimated $2.01M.
Nationwide Fund Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
Nationwide Fund Advisors's Momenta Pharmaceuticals, Inc. position peaked at $2.13M in Q2 2017.
166 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.